Company Filing History:
2 out of 5,309 
1 out of 2,119 
1 out of 1,308 
Years Active: 2016-2020
Title: Huiping Liu: Innovator in Cancer Diagnostics and Therapeutics
Introduction
Huiping Liu is a prominent inventor based in Chicago, IL, who has made significant contributions to the field of cancer diagnostics and therapeutics. With a total of 3 patents, her work focuses on utilizing advanced technologies to improve the detection and treatment of cancer.
Latest Patents
One of her latest patents is centered around extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer. This invention relates to the use of exosomes for biomarker analysis, enabling early detection and characterization of disease progression in cancer patients. Additionally, her invention provides bioengineered exosomes that can be utilized in methods for targeting and treating cancer effectively. Another notable patent involves methods and systems for the analysis of single cells. These methods facilitate the diagnosis and prognosis of diseases by analyzing the expression of a set of genes obtained from single-cell analysis. This classification allows for the optimization of treatment and helps determine whether to proceed with specific therapies, as well as how to optimize dosage and treatment choices.
Career Highlights
Throughout her career, Huiping Liu has worked with esteemed institutions such as Leland Stanford Junior University and Northwestern University. Her research has significantly advanced the understanding of cancer biology and therapeutic strategies.
Collaborations
Some of her notable collaborators include Michael F. Clarke and Stephen R. Quake, who have contributed to her innovative research endeavors.
Conclusion
Huiping Liu's contributions to cancer diagnostics and therapeutics through her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in cancer treatment and patient care.